Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 2/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | RAD52 | P43351 | 2/20 | 0.43 |
| ▸ | ELANE | P08246 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | IDE | P14735 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 6/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30766150 | 0.88 | GAA (0.52) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765807 | 0.87 | CASP1 (0.47) | GAAL3MBTL1ELANECASP1 | |
| SCHEMBL30765554 | 0.87 | KDM4E (0.44) | GAAL3MBTL1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL30766080 | 0.86 | MEN1 (0.45) | GAAL3MBTL1MEN1KMT2AAPAF1 | |
| SCHEMBL30765613 | 0.85 | GAA (0.50) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765668 | 0.83 | GAA (0.50) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765630 | 0.82 | GAA (0.47) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765790 | 0.82 | L3MBTL1 (0.53) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765532 | 0.82 | GAA (0.53) | GAAL3MBTL1MEN1KMT2ACYP1A2 | |
| SCHEMBL30765447 | 0.80 | L3MBTL1 (0.65) | GAAL3MBTL1MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568666-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | Alexion Pharmaceuticals, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| WO-2024035686-A1 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2024-02-15 | — | — | WO | disclosed |